Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Abdun-Nabi Daniel Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Exercised 3,571 restricted stock units @ $0
06/02/2023 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Exercised 297 restricted stock units @ $0
Granted 3,571 restricted stock units @ $0
03/07/2023 4/A Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
08/10/2022 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Granted 3,571 restricted stock units @ $0
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 10,000 options to buy @ $35.52, valued at $355.2k
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2020 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Disposed/sold 1,339 options to buy @ $0
Disposed/sold 892 options to buy @ $0
Disposed/sold 1,785 options to buy @ $0
Granted 1,322 options to buy @ $8.56, valued at $11.3k
Granted 170 options to buy @ $8.56, valued at $1.5k
06/02/2020 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 10,000 options to buy @ $37.66, valued at $376.6k
06/25/2019 4 Abdun-Nabi Daniel (Board of Directors) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Bought 16,667 shares @ $0.9, valued at $15k
06/04/2019 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 10,000 options to buy @ $43.02, valued at $430.2k
06/04/2019 4 Abdun-Nabi Daniel (Board of Directors) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $0.725, valued at $18.1k
03/04/2019 4 Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Sold 14,565 shares @ $58.107, valued at $846.3k
02/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/18/2018 4 Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Sold 28,220 shares @ $65, valued at $1.8M
Sold 1,319 shares @ $65, valued at $85.7k
Exercised 28,220 options to buy @ $13.38, valued at $377.6k
Exercised 1,319 options to buy @ $13.38, valued at $17.6k
09/06/2018 4 Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Sold 60,000 shares @ $60.5381, valued at $3.6M
Sold 30,776 shares @ $59.4926, valued at $1.8M
Exercised 60,000 options to buy @ $13.38, valued at $802.8k
06/07/2018 4 Abdun-Nabi Daniel (CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Sold 15,785 shares @ $52.1137, valued at $822.6k
06/04/2018 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $5.49, valued at $137.3k
05/30/2018 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 12,500 options to buy @ $49.45, valued at $618.1k
03/13/2018 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Paid exercise price by delivering 7,825 shares @ $51.84, valued at $405.6k
03/01/2018 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 13,371 shares @ $0
Paid exercise price by delivering 3,324 shares @ $49.64, valued at $165k
Paid exercise price by delivering 6,599 shares @ $49.97, valued at $329.8k
Granted 53,485 options to buy @ $49.64, valued at $2.7M
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2017 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Sold 20,000 shares @ $45.99, valued at $919.8k
Exercised 20,000 options to buy @ $14.44, valued at $288.8k
11/07/2017 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Sold 11,508 shares @ $42.5, valued at $489.1k
Sold 20,000 shares @ $42.92, valued at $858.4k
Exercised 11,508 options to buy @ $22.03, valued at $253.5k
Exercised 20,000 options to buy @ $14.44, valued at $288.8k
09/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2017 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Granted 12,500 options to buy @ $2.15, valued at $26.9k
05/26/2017 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 12,500 options to buy @ $18.85, valued at $235.6k
03/10/2017 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Paid exercise price by delivering 8,226 shares @ $30.98, valued at $254.8k
Paid exercise price by delivering 10,738 shares @ $31.05, valued at $333.4k
03/02/2017 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 19,588 shares @ $0
Granted 19,589 shares @ $0
Paid exercise price by delivering 6,184 shares @ $30.63, valued at $189.4k
Granted 78,329 options to buy @ $30.63, valued at $2.4M
03/01/2017 4 Abdun-Nabi Daniel (President & CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Exercised 3,662 shares @ $30.63, valued at $112.2k
Paid exercise price by delivering 1,735 shares @ $30.63, valued at $53.1k
Paid exercise price by delivering 984 shares @ $30.63, valued at $30.1k
Exercised 3,662 options to buy @ $14.51, valued at $53.1k
01/12/2017 4 Abdun-Nabi Daniel (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Acquired 1,979 shares @ $0
Acquired 3,032 shares @ $0
Acquired 3,419 shares @ $0
Sold 28,240 shares @ $31.2782, valued at $883.3k
Acquired 3,662 options to buy @ $14.51, valued at $53.1k
Exercised 38,006 options to buy @ $14.51, valued at $551.5k
08/09/2016 4 Abdun-Nabi Daniel (Director) has filed a Form 4 on REGENXBIO Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy